1069 IL-12 mRNA monotherapy is effective in murine tumors resistant to checkpoint inhibition by Katerina Politi, Marcus Bosenberg, Man Li, Jim Eyles, Sreevidya Santha, Jayalakshmi Lakshmipathi, Yuping Qian, Nadia Luheshi, Viswanathan Muthusamy

785 mAZD0171 mediated LIF blockade in combination with chemotherapy and PD-L1 inhibition repolarizes macrophages and increases T cell infiltration via CX3CR1-CX3CL1 axis by Scott Hammond, Robert Wilkinson, Michal Sulikowski, Jean-Martin Lapointe, Gozde Kar, Jim Eyles, Scott Hoffmann, Nadia Luheshi, Juliana Candido, Grace Opoku-Ansah, Fabien Garcon, Chelsea Gerada, Bairu Zhang, Rakesh Choudhary, Douglas C Palmer, Stewart Jones

Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models by Brajesh P. Kaistha, Gozde Kar, Andreas Dannhorn, Amanda Watkins, Grace Opoku-Ansah, Kristina Ilieva, Stefanie Mullins, Judith Anderton, Elena Galvani, Fabien Garcon, Jean-Martin Lapointe, Lee Brown, James Hair, Tim Slidel, Nadia Luheshi, Kelli Ryan, Elizabeth Hardaker, Simon Dovedi, Rakesh Kumar, Robert W. Wilkinson, Scott A. Hammond, Jim Eyles

Get full text

Integrating IL-12 mRNA nanotechnology with SBRT eliminates T cell exhaustion in preclinical models of pancreatic cancer by Angela L. Hughson, Gary Hannon, Noah A. Salama, Tara G. Vrooman, Caroline A. Stockwell, Bradley N. Mills, Jesse Garrett-Larsen, Haoming Qiu, Roula Katerji, Lauren Benoodt, Carl J. Johnston, Joseph D. Murphy, Emma Kruger, Jian Ye, Nicholas W. Gavras, David C. Keeley, Shuyang S. Qin, Maggie L. Lesch, Jason B. Muhitch, Tanzy M.T. Love, Laura M. Calvi, Edith M. Lord, Nadia Luheshi, Jim Elyes, David C. Linehan, Scott A. Gerber

Get full text